MiniMed Group

MiniMed Group

MiniMed Group traces its origins to Alfred E. Mann's medical device career, which spanned founding Pacesetter Systems (sold to Siemens in 1985), MiniMed, Inc. (sold to Medtronic in 2001), and Advanced Bionics (sold to Boston Scientific in 2004). The office manages capital generated from those exits, with Mann personally directing philanthropic and investment activities through a network of related entities until his death in 2016. The office's investment strategy centered on healthcare and life sciences during Mann's lifetime, reflecting his operating expertise. Direct venture investments in medical device startups and biotechnology companies historically dominated the portfolio. Specific investment activity and current deployment volume remain private; the office has not disclosed a stated asset allocation or fund commitment strategy. MiniMed Group operated without a public-facing website or disclosed team roster. Alfred Mann ran the office directly, often co-investing alongside his foundations—the Alfred Mann Foundation and the Alfred E. Mann Institute for Biomedical Engineering at USC—which collectively held significant equity stakes in the ventures he backed. Between 2001 and 2016, Mann deployed hundreds of millions through these parallel structures, often taking board seats at portfolio companies. The structural differentiator is its integration with academic research institutions. Through the Alfred E. Mann Institute at USC and a now-closed counterpart at the Technion, Mann commercialized university-developed biomedical technologies using his own capital—a model that blended philanthropy, technology transfer, and direct investing under a single operating philosophy. Governance after Mann's death is not publicly documented.